ArticleNano letters2017

Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.

Charalambos Kaittanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.